Dow Jones

40 211,72

0,53%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
22/08/2019	22h12	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:INSM	Insmed Inc
02/08/2019	22h05	PR Newswire (US)	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:INSM	Insmed Inc
01/08/2019	13h34	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:INSM	Insmed Inc
01/08/2019	13h32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INSM	Insmed Inc
01/08/2019	13h30	PR Newswire (US)	Insmed Reports Second Quarter 2019 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
25/07/2019	14h00	PR Newswire (US)	Insmed to Host Second Quarter 2019 Financial Results Conference Call on Thursday, August 1, 2019	NASDAQ:INSM	Insmed Inc
26/06/2019	22h50	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:INSM	Insmed Inc
26/06/2019	22h41	PR Newswire (US)	Insmed Announces Closing of Public Offering of Common Stock	NASDAQ:INSM	Insmed Inc
25/06/2019	22h07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
12/06/2019	22h07	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:INSM	Insmed Inc
06/06/2019	14h00	PR Newswire (US)	Insmed to Present at the Goldman Sachs 40th Annual Global Healthcare Conference	NASDAQ:INSM	Insmed Inc
23/05/2019	12h04	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:INSM	Insmed Inc
22/05/2019	12h03	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NASDAQ:INSM	Insmed Inc
22/05/2019	02h56	PR Newswire (US)	Insmed Announces Pricing of Public Offering of Common Stock	NASDAQ:INSM	Insmed Inc
20/05/2019	22h05	PR Newswire (US)	Insmed Announces Proposed Public Offering of Common Stock	NASDAQ:INSM	Insmed Inc
20/05/2019	22h01	PR Newswire (US)	New Phase 3 Data Show Sustainability and Durability of Culture Conversion with ARIKAYCE® (amikacin liposome inhalation suspe...	NASDAQ:INSM	Insmed Inc
07/05/2019	13h30	PR Newswire (US)	Insmed Reports First Quarter 2019 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
30/04/2019	14h00	PR Newswire (US)	Insmed to Host First Quarter 2019 Financial Results Conference Call on Tuesday, May 7, 2019	NASDAQ:INSM	Insmed Inc
09/04/2019	22h36	PR Newswire (US)	Insmed Granted Additional U.S. Patent For ARIKAYCE® (amikacin liposome inhalation suspension), Strengthening Brand's Global ...	NASDAQ:INSM	Insmed Inc
08/04/2019	11h00	PR Newswire (US)	Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch	NASDAQ:INSM	Insmed Inc
04/04/2019	22h08	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:INSM	Insmed Inc
04/04/2019	22h07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:INSM	Insmed Inc
01/04/2019	22h05	PR Newswire (US)	Insmed To Showcase New ARIKAYCE® (amikacin liposome inhalation suspension) And Pipeline Data At American Thoracic Society In...	NASDAQ:INSM	Insmed Inc
01/04/2019	14h00	PR Newswire (US)	Insmed to Present at the H.C. Wainwright Global Life Sciences Conference	NASDAQ:INSM	Insmed Inc
27/03/2019	21h15	PR Newswire (US)	Insmed Announces Management Changes	NASDAQ:INSM	Insmed Inc
18/03/2019	16h32	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:INSM	Insmed Inc
22/02/2019	13h33	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:INSM	Insmed Inc
22/02/2019	13h30	PR Newswire (US)	Insmed Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
20/02/2019	14h00	PR Newswire (US)	Insmed to Present at the Leerink Partners 8th Annual Global Healthcare Conference	NASDAQ:INSM	Insmed Inc
15/02/2019	14h00	PR Newswire (US)	Insmed to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call on Friday, February 22, 2019	NASDAQ:INSM	Insmed Inc